DB

Devi Bala Huidrom

Active Director Director DIN 08730905
DIN 08730905 First appointment Mar 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Devi Bala Huidrom

Data last updated:

Devi Bala Huidrom is a Director at Leichal Taret Foundation (since 2020). The company operates in Healthcare. Leichal Taret Foundation reported revenue of ₹2.9 Lakh (FY 2025).

DIN 08730905
Primary Designation Director
Industry Healthcare
First Appointment 27 Mar 2020
Oldest Company Age 6 yrs
Largest company Leichal Taret Foundation · ₹2.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leichal Taret Foundation U85100PN2020NPL190507
Director27 Mar 20202020₹2.9 Lakh (FY 2025)Active

Board colleagues of Devi Bala Huidrom

Directorship timeline

Open interactive timeline →
Leichal Taret Foundation
Premium access

Shareholding and investment profile for Devi Bala Huidrom

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devi Bala Huidrom

Devi Bala Huidrom currently holds 1 directorship: Leichal Taret Foundation (Director, since 27 Mar 2020, revenue ₹2.9 Lakh (FY 2025)).

Devi Bala Huidrom was first appointed on 27 Mar 2020 as Director at Leichal Taret Foundation.

The current boards of Devi Bala Huidrom's companies include Chanam Pramodini Devi (Leichal Taret Foundation), Kshetrimayum Manteshori Devi (Leichal Taret Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available